Xuan Kan
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 4
-
- Cell Adhesion Molecules Research 4
-
- RNA modifications and cancer 6
- Cancer-related gene regulation 4
- Circular RNAs in diseases 4
- PI3K/AKT/mTOR signaling in cancer 2
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Liang LiJian LuJingting WangLinli TianYong LiQiuying LiWenliang ZhuJingyuan Ren
- Partner nations
- ChinaUnited States
In The Last Decade
Xuan Kan
29 papers receiving 492 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 257
- Immunology and Allergy 35
- Molecular Biology 349
- Oncology 78
- Otorhinolaryngology 12
Countries citing papers authored by Xuan Kan
This map shows the geographic impact of Xuan Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Kan more than expected).
Fields of papers citing papers by Xuan Kan
This network shows the impact of papers produced by Xuan Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Kan. The network helps show where Xuan Kan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuan Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 23 | |
| 11 | 2022 | 14 | |
| 12 | 2021 | 30 | |
| 13 | 2020 | 30 | |
| 14 | 2020 | 14 | |
| 15 | 2018 | 28 | |
| 16 | 2016 | 22 | |
| 17 | 2015 | 23 | |
| 18 | 2014 | 22 | |
| 19 | 2014 | 11 | |
| 20 | 2012 | 25 |
About Xuan Kan
Xuan Kan is a scholar working on Cancer Research, Immunology and Allergy and Business and International Management, having authored 35 papers that have together received 493 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (6 papers), MicroRNA in disease regulation (4 papers), Cancer-related gene regulation (4 papers), Circular RNAs in diseases (4 papers), Cell Adhesion Molecules Research (4 papers), Ferroptosis and cancer prognosis (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Cancer Research (257 citations), Immunology and Allergy (35 citations) and Molecular Biology (349 citations). Xuan Kan has collaborated with scholars based in China and United States. Frequent co-authors include Liang Li, Jian Lu, Jingting Wang, Linli Tian, Yong Li, Qiuying Li, Wenliang Zhu, Jingyuan Ren, Yujian Li and Lingmei Qu. Their work appears in journals such as PLoS ONE, Journal of Controlled Release and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.